Cargando…
Bone mesenchymal stromal cells exhibit functional inhibition but no chromosomal aberrations in chronic myelogenous leukemia
Chronic myelogenous leukemia (CML) is a myeloproliferative neoplasia characterized by the presence of the Philadelphia (Ph) chromosome in hematopoietic cells (HCs). As one of the most important components of the bone marrow microenvironment (BMM), bone mesenchymal stromal cells (BMSCs) are critical...
Autores principales: | Xie, Jieqiong, Chen, Jiadi, Wang, Bin, He, Xuchun, Huang, Huifang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6312938/ https://www.ncbi.nlm.nih.gov/pubmed/30655859 http://dx.doi.org/10.3892/ol.2018.9681 |
Ejemplares similares
-
Impact of Additional Chromosomal Aberrations on the Disease Progression of Chronic Myelogenous Leukemia
por: Krishna Chandran, Ramachandran, et al.
Publicado: (2019) -
Analysis of Chromosomal Aberrations and FLT3 gene Mutations in Childhood Acute Myelogenous Leukemia Patients
por: Coşkunpınar, Ender, et al.
Publicado: (2012) -
Mesenchymal stromal cells derived from acute myeloid leukemia bone marrow exhibit aberrant cytogenetics and cytokine elaboration
por: Huang, J C, et al.
Publicado: (2015) -
Bone marrow mesenchymal stromal cells from acute myelogenous leukemia patients demonstrate adipogenic differentiation propensity with implications for leukemia cell support
por: Azadniv, Mitra, et al.
Publicado: (2019) -
Chronic myelogenous leukemia in Libya
por: Mehdi, Itrat, et al.
Publicado: (2012)